Choosing China: Akeso’s $3M Beginnings and the Rise of China’s Biotech Sector When Akeso was starting out some 13 years ago, the leadership team had $3 million and a bold goal to move China’s drug industry toward innovation. When Akeso…
Pioneering sustainable transatlantic transport to cut emissions in pharmaceutical supply chains Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the U.S. using…
Sanofi Joins Growing Group of Pharmas Pulling Back From UK Merck, Eli Lilly and AstraZeneca have similarly suspended or outright canceled investments in the U.K. in the past week after a sizeable increase in a mandatory levy in the region…
Royalty Pharma and Deloitte Release Landmark Study on the Role of Royalties in Funding Biopharma Innovation Royalty Pharma plc (Nasdaq: RPRX), the world’s largest acquirer of biopharmaceutical royalties and a key investor in life sciences innovation, has announced the publication…
Alnylam Pharmaceuticals Prices Upsized $575 Million Convertible Senior Notes Offering, Strengthening Balance Sheet and Advancing Growth Strategy Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a recognized global leader in RNA interference (RNAi) therapeutics, has announced the successful pricing of its private offering…
Cascade Bio Secures $6 Million to Advance Biocatalyst Innovation and Transform Biomanufacturing In a world grappling with climate change, supply chain disruptions, and the growing demand for sustainable manufacturing, biotechnology companies are racing to create alternatives to petrochemical-based production. Cascade…
JCR Pharmaceuticals Showcases Landmark Five-Year Clinical Data on Pabinafusp Alfa at ICIEM 2025, Reinforcing Transformative Potential for Patients with Hunter Syndrome and Expanding Pipeline of Brain-Penetrant Enzyme Replacement Therapies In early September 2025, the city of Kyoto, Japan, became the…
Roche’s Vabysmo Reinforces Long-Term Benefits in Wet Age-Related Macular Degeneration and Shows Strong Gains in Polypoidal Choroidal Vasculopathy Paris, France – At the 25th annual Euretina Congress, one of the world’s most important scientific gatherings focused on retinal disease, Roche…
Octave Bioscience Secures $35.6 Million Series C Financing and $15.5 Million Loan to Accelerate Growth and Advance Precision Care in Neurology Octave Bioscience, Inc., a commercial-stage precision care company dedicated to transforming the management of neurodegenerative diseases, has announced a…
Walgreens Embarks on New Era as Private Standalone Company Following Acquisition by Sycamore Partners Walgreen Co. (“Walgreens” or “the Company”), one of America’s most iconic retail pharmacy chains and a cornerstone of healthcare access for millions of Americans, announced today…
Evolus Reports Positive Pivotal Trial Data for Evolysse™ Sculpt Hyaluronic Acid Gel at 2025 Cosmetic Bootcamp, Marking a Major Milestone in Aesthetic Innovation Evolus, Inc. (NASDAQ: EOLS), a fast-growing performance beauty company dedicated to reshaping the aesthetic medicine landscape, announced…
Sarepta Therapeutics Restructures $700 Million in Convertible Debt, Extending Maturities and Strengthening Financial Flexibility Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leader in precision genetic medicine focused on rare diseases, has announced a significant refinancing transaction designed to strengthen its capital…